← FDA Drug Approvals (Drugs@FDA)

DEXAMETHASONE SODIUM PHOSPHATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GENEYORK PHARMS · Approved 2023-07-07

Drug application

FDA Application #

ANDA214890

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEXAMETHASONE SODIUM PHOSPHATE

Generic name

Dexamethasone Sodium Phosphate

Active ingredients

DEXAMETHASONE SODIUM PHOSPHATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

GENEYORK PHARMS

First approval

2023-07-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown